Services offered include: Fungal identification, the in vitro susceptibility testing of antifungal drugs, the measurement of levels of antimycotic agents in biological tissues and fluids, and the evaluation of antifungal properties of potential and new antifungal drugs. The Fungus Testing Laboratory has been particularly active in the screening and testing of newly licensed antifungal antimicrobics for the pharmaceutical industry and serves as the contract laboratory for clinical efficacy studies involving these agents in therapeutic and clinical trials in humans for the major drug companies involved in the development of such antimicrobial agents.
PLEASE NOTE: Yeast identification now offered by MALDI-TOF MS. Testing is reflexed to routine identification (DNA sequence analysis and phenotypic characteristics) if unable to identify the species by MALDI-TOF MS.
PLEASE NOTE: Beginning December 15, 2021, we will no longer offer DNA probe identification of Coccidioides, Blastomyces, or Histoplasma species. Identifications of these fungi will be performed by routine identification (DNA sequence analysis and phenotypic characteristics).
PLEASE NOTE: That ketoconazole susceptibility testing will no longer be performed by the Fungus Testing Laboratory after January 14, 2022.
Nathan P. Wiederhold, Pharm. D.
The Fungus Testing Laboratory at the University of Texas
Health Science Center will be closed and unable to receive
shipments on the following dates:
November 25, 2021
November 26, 2021
December 24, 2021
December 27, 2021
December 31, 2021
January 17, 2022
February 21, 2022
April 8, 2022
May 30, 2022
July 4, 2022
Please contact us at 210-567-4131 if you have any
questions or concerns.